Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising.
- The platform is designed to detect cocaine, cannabis, alcohol, narcotics, psychedelics, and human fatigue using voice analysis and artificial intelligence.
- MindBio is preparing to deploy the software through Edge AI kiosk systems targeted at safety-critical industries.
- The company is pursuing commercialization opportunities in mining, aviation, construction, transportation, and law enforcement markets.
- MindBio’s technology offers a non-invasive and affordable alternative to traditional drug and alcohol testing methods.
- The launch represents a key step in the company’s transition from research and clinical development toward commercial implementation.
MindBio Therapeutics (CSE: MBIO) (OTCQB: MBQIF), a biotechnology company, has launched Intox AI(TM), its flagship enterprise software platform designed to detect drug use, alcohol intoxication, and human fatigue, through voice analysis powered by artificial intelligence. The announcement marks an important milestone in the company’s commercialization strategy as it moves toward deployment of its first Edge AI kiosk prototypes, which are expected to be completed during the current quarter (https://ibn.fm/GrITB).
According to MindBio, Intox AI(TM) is designed to analyze speech patterns in real time and identify indicators associated with multiple neurologically active substances, including cocaine, cannabis, alcohol, psychedelics, and narcotics. The platform is also being developed to assess human fatigue, a factor that…
NOTE TO INVESTORS: The latest news and updates relating to MBQIF are available in the company’s newsroom at https://ibn.fm/MBQIF
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
Editor@InvestorWire.com
InvestorWire is powered by IBN
